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Information on problem drug use is collected by the National Drug Treatment Reporting
System (NDTRS). The NDTRS is an epidemiological database on treated drug misuse. It was
established in 1990 in the Greater Dublin Area only. In 1995 it was extended to cover other
areas of the country including the Midland Health Board (MHB) area. The objectives of the
NDTRS are to provide reliable information on the number and characteristics of people
who are treated for problem drug use, and to examine trends and patterns of problem
drug use. It provides information relevant to the health consequences and social
implications of drug misuse and contributes to an understanding of the epidemiology of
drug misuse in Ireland. This series of papers presents data by regional health board areas. 
NDTRS methodology
Background
Data on treated drug misuse are routinely collected by staff at drug treatment agencies
throughout Ireland. Compliance with the NDTRS requires that a form be completed for each
person who receives treatment for problematic drug use.  At national level, aggregated
anonymous data are compiled by the Drug Misuse Research Division (DMRD), Health Research
Board (HRB). 
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to
ameliorate the psychological, medical or social state of individuals who seek help for their drug
problems’. Treatment may therefore include non-medical (addiction counselling, group therapy,
psychotherapy), as well as medical interventions (detoxification, methadone substitution
programmes).  
The main elements of the reporting system are: 
a) All Treatment Contacts – the reporting of all clients receiving treatment during a given year,
and 
b) First Treatment Contacts – the reporting of the sub-group of clients who have never previously
been treated for problem drug use.
In the case of the ‘all contact’ data there is a possibility of duplication of individuals in the
database, for example, where a person receives treatment at more than one centre.  This is
estimated to be small since the introduction of the Misuse of Drugs Regulations in 1998,
whereby precautions are taken to ensure that treatment by way of medical prescription is
available from one source only.  
Treatment as an indicator of drug misuse
Drug treatment data are viewed as an indirect indicator of drug misuse and are used at
national and European levels to provide information on the characteristics of clients
entering treatment, and patterns of drug misuse such as types of drugs used and
consumption behaviours. They are ‘valuable from a public health perspective to assess
needs, … and to plan and evaluate services’ (EMCDDA, 1998: 23). Information from the
NDTRS is made available to service providers and policy makers and forms an important
Table 1a. Number of All Treatment Contacts* by treatment area and area of residence of clients,
1996-2000
Year Total treated in MHB MHB residents MHB residents Others treated in Total MHB residents
treated in MHB treated elsewhere MHB treated
1996 63 62 8 1 70
1997 61 61 5 0 66
1998 85 85 11 0 96
1999 128 127 16 1 143
2000 150 150 18** 0 168**
* Number of cases, as distinct from individuals, who received treatment for their problem drug use
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
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With the recognition that there can be serious risk of damage to the health and well being of individuals by
the misuse of psychoactive substances, the emphasis of drug policy in the MHB area is on education and
prevention (Department of Public Health, 1999). The policy, which is set in the wider context of health
promotion, aims to adopt a multi-stranded, multi-agency approach involving mainstream health services, 
an Garda Siochána, parents and youth and community services (http://www.mhb.ie).  
Drug treatment in the MHB area is provided by two main services: the Community and Alcohol Addiction Service
and the Laois/Offaly Mental Health Service. Data for the NDTRS during 2000 were collected at seven locations.
All 150 contacts during 2000 were treated in non-residential centres. The type of drug treatment
provided/availed of was mainly advice/counselling/support (N=142). The treatment provided to any one
individual may include a combination of options. During 2000, as well as addiction counselling, 30 clients
participated in a drug substitution/maintenance programme, and 11 clients underwent detoxification 
from drugs.  
The number of drug users presenting for treatment in the MHB has more than doubled in the five-year
period 1996 to 2000. In 1996, 63 clients received treatment2 for problematic drug use in the MHB area. By
2000 the number had increased to 150 (Table 1a). Each year, except 1999, the number treated in the MHB
catchment area was less than the total number of MHB residents who received treatment. In 2000, for
example, 18 residents of the MHB area were treated elsewhere (Table 1a).
Extent of the problem
1 Counties Laois, Longford, Offaly and Westmeath
2 The emphasis of this paper is on the illicit drug use of clients who received treatment between 1996 and 2000, in the catchment area covered    
by the MHB (Counties Laois, Longford, Offaly and Westmeath)
Treatment provision
element in informing local and national drug policies. Based on NDTRS data a number of local areas
were targeted for special attention in 1996 (Ministerial Task Force, 1996). Initially eleven areas, ten in
Dublin and one in Cork, all of which were characterised by social and economic disadvantage, were
designated as Local Drug Task Force Areas (Ministerial Task Force, 1996). There are now fourteen areas:
twelve in Dublin; one in Cork; and one in Bray (Department of Tourism, Sport & Recreation, 2001).
Local Drug Task Forces were established with the aim of providing strategic local responses in areas
where drug misuse was a serious problem.
In the Government’s Building on Experience. National Drugs Strategy 2001-2008, the role of the NDTRS is
recognised in ensuring that the overall aims of the strategy are met. NDTRS data collection is one of the
actions identified and agreed by Government for implementation by health boards. It is stated that ‘all
treatment providers should co-operate in returning information on problem drug use to the DMRD of
the HRB’ (Department of Tourism, Sport & Recreation, 2001: 118). 
The MHB is committed to the establishment and development of standardised mechanisms for data
collection relevant to ongoing monitoring of service delivery levels, needs assessment and service
planning (Midland Health Board, 1999).
The emphasis of
drug policy in
the MHB area is
on education
and prevention
During 2000,
168 MHB
residents were
treated for
problem drug
use
Table 1b. Number of First Treatment Contacts* by treatment area and area of residence of 
clients, 1996-2000
Year Total treated in MHB MHB residents MHB residents Others treated in Total MHB residents
treated in MHB treated elsewhere MHB treated
1996 49 48 6 1 54
1997 34 34 2 0 36
1998 39 39 7 0 46
1999 76 76 8 0 84
2000 87 87 13** 0 100**
* Number of people who received treatment for the first time ever
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
Table 2a. Socio-demographic characteristics of All Treatment Contacts treated in the MHB, 
1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 90:10 92:08 86:14 85:15 82:18
Mean age (years) 22 24 24 23 24
Modal age (years) 19 19 20 18, 20 23
% Under 18 years of age 19 18 13 19 10
% Living with parents/family 71 66 67 74 63
% Early school leavers* 10 16 14 17 23
% Still at school 14 20 14 15 8
% Employed 13 18 24 34 41
* Left school before the age of 15 years
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The typical client coming for treatment is male, in his late teens or early twenties and living in the family
home. Clients were slightly older in 2000 than in 1996 - the mean age for all contacts increased from 22
in 1996 to 24 years of age in 2000; the most frequently occurring age (modal age) increased from 19 in
1996 to 23 years of age in 2000 (Table 2a). The educational profile of clients did not improve over the
period 1996 to 2000 - in 2000 they were more likely to have left school before the official school leaving
age of 15 years (23 percent) compared to 1996 (10 percent) (Table 2a). One aspect of the social
condition of clients did improve remarkably - the employment level increased from 13 percent in 1996 to
41 percent in 2000. This is as might be expected, given the general favourable economic conditions in
the country.  
Socio-demographic information
A sizeable proportion (over half) of those treated each year are receiving treatment for the first time (first
contacts). The number of first contacts increased from 49 in 1996 to 87 in 2000 (Table 1b).  
Trends in the socio-demographic characteristics of new clients (first contacts) are generally quite similar
to those of the overall group of all contacts (Table 2b).  
The typical client
coming for
treatment is
male, in his late
teens or early
twenties and
living in the
family home
Table 2b. Socio-demographic characteristics of First Treatment Contacts treated in the MHB, 
1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 91:09 91:09 87:13 88:12 83:17
Mean age (years) 21 22 21 21 22
Modal age (years) 19 19 18, 20 18 20
% Under 18 years of age 20 27 19 22 15
% Living with parents/family 82 74 68 79 67
% Early school leavers* 8 14 14 15 26
% Still at school 13 31 19 20 12
% Employed 16 18 21 38 45
* Left school before the age of 15 years
Table 3a. Main Drug of Misuse of All Treatment Contacts treated in the MHB, 1996-2000 
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates 7 (11) 8 (13) 23 (27) 35 (27) 57 (38)
Cocaine 0 (0) 0 (0) 0 (0) 0 (0) 2 (1)
Ecstasy 8 (13) 6 (10) 5 (6) 11 (9) 19 (13)
Amphetamines 1 (2) 2 (3) 2 (2) 4 (3) 1 (1)
Benzodiazepines 0 (0) 2 (3) 2 (2) 1 (1) 1 (1)
Volatile Inhalants 4 (6) 5 (8) 5 (6) 1 (1) 2 (1)
Cannabis 42 (67) 37 (61) 46 (54) 74 (58) 67 (45)
Other substances 1 (2) 1 (2) 2 (2) 2 (2) 1 (1)
Total 63 61 85 128 150
Table 3b. Main Drug of Misuse of First Treatment Contacts treated in the MHB, 1996-2000 
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates 4 (8) 1 (3) 7 (18) 8 (11) 22 (25)
Cocaine 0 (0) 0 (0) 0 (0) 0 (0) 1 (1)
Ecstasy 7 (14) 4 (12) 4 (10) 9 (12) 13 (15)
Amphetamines 1 (2) 2 (6) 0 (0) 1 (1) 0 (0)
Benzodiazepines 0 (0) 2 (6) 0 (0) 1 (1) 1 (1)
Volatile Inhalants 3 (6) 3 (9) 3 (8) 1 (1) 2 (2)
Cannabis 33 (67) 22 (65) 23 (59) 55 (72) 48 (55)
Other substances 1 (2) 0 (0) 2 (5) 1 (1) 0 (0)
Total 49 34 39 76 87
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Information on patterns of drug use, such as the types of drugs used, how they are taken, and whether in
combination with other drugs, can be useful in assessing and planning drug treatment services. In the
MHB area, drug use patterns are generally similar to those in other regions of the country where cannabis
is the main drug causing problems and for which most people present for treatment (O’Brien et al. 2000).
Given that cannabis is smoked, this can have serious implications for the future health of a young
population. Trends over the period 1996 to 2000 show that while the number presenting for treatment for
cannabis misuse has increased, the relative proportion has decreased from 67 percent in 1996 to 45
percent in 2000 (Table 3a). Unlike most other regions where cannabis is usually followed by ecstasy as the
main drug of misuse, in the MHB cannabis is followed by opiates as the main drug of choice. Since 1997,
(after cannabis) opiates are the drugs causing problems and for which people present for treatment.
Opiate use shows an increasing trend from 11 percent in 1996 to 38 percent in 2000.
Problem drug use
A cause for concern is the fact that there is a similar trend of increasing opiate use among new clients
(first contacts). While the numbers are relatively small, the proportion of people presenting for treatment
of problematic opiate use increased from 8 percent (N=4) in 1996 to 25 percent (N=22) in 2000 (Table
3b). The increase could be partly explained by an increase in service provision, but undoubtedly also
points to an increase in opiate use.  
A closer scrutiny of all treatment contacts reveals that heroin was the opiate most likely to be used and
that the number increased from 6 (10 percent of the total number treated) in 1996 to 56 in 2000 (37
percent of the total treated) (Table 4a). The fact that heroin was more likely to be injected than smoked
has serious health implications (Table 4a).   
Cannabis is
followed by
opiates as the
main drug of
choice
There is a
trend towards
increasing
opiate use
among new
clients
Table 4a. Opiate as a Main Drug of Misuse for All Treatment Contacts treated in the MHB, 1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 6 7 19 33 56
of whom:
inject 3 6 10 22 33
smoke 3 1 9 11 22
other 0 0 0 0 0
not known 0 0 0 0 1
Other Opiates 1 1 4 2 1
Total 7 8 23 35 57
Table 4b. Opiate as a Main Drug of Misuse for First Treatment Contacts treated in the MHB, 
1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 3 1 7 8 22
of whom:
inject 1 1 2 3 6
smoke 2 0 5 5 16
other route 0 0 0 0 0
Other Opiates 1 0 0 0 0
Total 4 1 7 8 22
Table 5a. Secondary Drug of Misuse of All Treatment Contacts treated in the MHB, 1996-2000 
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug 26 (41) 18 (30) 23 (27) 46 (36) 41 (27)
Opiates 3 (5) 3 (5) 0 (0) 0 (0) 0 (0)
Cocaine 1 (2) 0 (0) 0 (0) 2 (2) 6 (4)
Ecstasy 8 (13) 15 (25) 18 (21) 35 (27) 39 (26)
Amphetamines 2 (3) 1 (2) 12 (14) 13 (10) 4 (3)
Benzodiazepines 1 (2) 2 (3) 2 (2) 2 (2) 8 (5)
Volatile Inhalants 0 (0) 0 (0) 0 (0) 1 (1) 1 (1)
Cannabis 7 (11) 10 (16) 21 (25) 26 (20) 46 (31)
Alcohol 10 (16) 6 (10) 3 (4) 2 (2) 3 (2)
Other substances 5 (8) 6 (10) 6 (7) 1 (1) 2 (1)
Total 63 61 85 128 150
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While heroin use is relatively low among new clients there is a trend towards increasing use, leaving no
room for complacency (Table 4b).
Polydrug use is very much a feature of drug use patterns. The proportion of clients involved in the use of
more than one drug increased over the five-year period, from 59 percent in 1996, to 73 percent in 2000
(Table 5a). Cannabis and ecstasy are the drugs most likely to be reported and show an increasing trend.
Very few cases of alcohol3 use are reported, and considering that ‘a high prevalence’ of alcohol use was
highlighted in a study of midlands youth (Sheerin, 1999: 37), it is surprising that this is not reflected in
the returns to the NDTRS. However, the fact that ‘there was widespread consensus among young people
that drinking is generally ‘not a problem’’ (Sheerin, 1999: 38), may explain why young people are not
presenting for treatment of alcohol use.  
Polydrug use
is very much
a feature of
drug use
patterns
A majority of new clients were polydrug users (Table 5b). Trends among new clients were similar to those
among all contacts, except that in 2000 first contacts were more likely than the overall group of all
contacts to use ecstasy than cannabis (Table 5b). 
3 Alcohol may be included as a secondary drug of misuse in the NDTRS. It is NOT included as a main drug
Table 6a. Risk Behaviours of All Treatment Contacts treated in the MHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 16 17 17 16 16
Mean age 1st injected (years) 20 19 22 19 20
Ever Injected  N 6 8 12 28 45
of whom:
‘ever shared’  N 3 5 5 15 31
‘currently injecting’  N 1 4 6 5 16
‘currently sharing’  N 1 2 3 1 6
Table 6b. Risk Behaviours of First Treatment Contacts treated in the MHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 16 17 16 16 15
Mean age 1st injected (years) 21 Na 16 19 21
Ever Injected  N 3 1 3 4 12
of whom:
‘ever shared’  N 2 1 1 2 5
‘currently injecting’  N 0 1 0 1 6
‘currently sharing’  N 0 1 0 0 3
Na: Not available
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Over the five-year period the mean age of initial drug use remained consistently young at 16 or 17 years
of age (Tables 6a). There was an increase in injecting drug use. The number of clients who had ever
injected was relatively low, but increased from 6 in 1996 to 45 in 2000. Of these, a sizeable proportion
engaged in high risk behaviour: in 2000, more than two-thirds (31 out of 45) had shared injecting
equipment, and a third (16 out of 45) were currently injecting drugs (Table 6a). The age at which they
started to inject was between 2 years (in 1997) and 4 years (2000) after initial drug use. The increasing
trend of injecting drug use presents issues of particular concern for the health of drug users and a
challenge to service providers.   
Risk behaviour
Among the first contact sub-group the number who had ever injected is low, but it is also increasing
(from 3 in 1996 to 12 in 2000), and the fact that they are likely to be involved in high risk behaviour
such as sharing injecting equipment cannot be ignored (Table 6b).  
Table 5b. Secondary Drug of Misuse of First Treatment Contacts treated in the MHB, 1996-2000 
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug 22 (45) 11 (32) 10 (26) 35 (46) 28 (32)
Opiates 2 (4) 2 (6) 0 (0) 0 (0) 0 (0)
Cocaine 1 (2) 0 (0) 0 (0) 0 (0) 2 (2)
Ecstasy 5 (10) 8 (24) 8 (21) 25 (33) 29 (33)
Amphetamines 2 (4) 1 (3) 5 (13) 7 (9) 2 (2)
Benzodiazepines 0 (0) 1 (3) 0 (0) 0 (0) 1 (1)
Volatile Inhalants 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Cannabis 6 (12) 5 (15) 10 (26) 9 (12) 24 (28)
Alcohol 6 (12) 2 (6) 3 (8) 0 (0) 0 (0)
Other substances 5 (10) 4 (12) 3 (8) 0 (0) 1 (1)
Total 49 34 39 76 87
Mean age of
initial drug use
remained
consistently
young at 16 or
17 years of age
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Figure 1a. Trends in All Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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Figure 1b. Trends in First Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
Year
Figures 1a and 1b provide a comparison of the rates of treated drug misuse among residents in different health
board areas of Ireland for all and first treatment contacts respectively. As the majority of people treated for
problem drug use are in the 15-39 year age group, the rates were based on this age group of the population
in each health board area. It is immediately obvious that in the ERHA health board areas (formerly EHB) the
rate is much higher than in other regions of the country. However, there is not great variation in regional
trends. In all cases the trend shows an increase in those presenting to drug treatment services (Figure 1a). 
Regional trends
There was an upward trend in first treatment contacts between 1996 and 2000 in all regions
(Figure 1b). Increased provision of services at individual health board level is of course a factor
that must be borne in mind when considering such trends. Where there are accessible drug user
oriented services provided, people are more likely to approach them. However, it would appear
that the upward trends also indicate a real increase in drug misuse.   
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